ATE137747T1 - Aminobenzolverbindungen, herstellung und verwendung - Google Patents

Aminobenzolverbindungen, herstellung und verwendung

Info

Publication number
ATE137747T1
ATE137747T1 AT91104745T AT91104745T ATE137747T1 AT E137747 T1 ATE137747 T1 AT E137747T1 AT 91104745 T AT91104745 T AT 91104745T AT 91104745 T AT91104745 T AT 91104745T AT E137747 T1 ATE137747 T1 AT E137747T1
Authority
AT
Austria
Prior art keywords
optionally substituted
hydrogen atom
group
chem
formula
Prior art date
Application number
AT91104745T
Other languages
English (en)
Inventor
Giichi Goto
Hidefumi Yukimasa
Masaomi Miyamoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE137747T1 publication Critical patent/ATE137747T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91104745T 1990-03-26 1991-03-26 Aminobenzolverbindungen, herstellung und verwendung ATE137747T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7717890 1990-03-26
JP16908990 1990-06-27
JP05075391A JP3280040B2 (ja) 1990-03-26 1991-02-21 アミノベンゼン化合物

Publications (1)

Publication Number Publication Date
ATE137747T1 true ATE137747T1 (de) 1996-05-15

Family

ID=27294061

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91104745T ATE137747T1 (de) 1990-03-26 1991-03-26 Aminobenzolverbindungen, herstellung und verwendung

Country Status (5)

Country Link
EP (1) EP0449195B1 (de)
JP (1) JP3280040B2 (de)
AT (1) ATE137747T1 (de)
CA (1) CA2038962A1 (de)
DE (1) DE69119282T2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE251141T1 (de) 1995-03-10 2003-10-15 Berlex Lab Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
JP3065506B2 (ja) * 1995-04-03 2000-07-17 株式会社資生堂 ピラゾリジン誘導体及びラジカルスカベンジャー、脳梗塞抑制剤、脳浮腫抑制剤
US5977138A (en) * 1996-08-15 1999-11-02 Schering Corporation Ether muscarinic antagonists
US6686364B2 (en) 1997-12-08 2004-02-03 Berlex Laboratories, Inc. Benzamidine derivatives and their use as anti-coagulants
US6262088B1 (en) 1998-11-19 2001-07-17 Berlex Laboratories, Inc. Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
US6350761B1 (en) * 1999-07-30 2002-02-26 Berlex Laboratories, Inc. Benzenamine derivatives as anti-coagulants
AU8112101A (en) * 2000-08-08 2002-02-18 Ortho Mcneil Pharm Inc Non-imidazole aryloxypiperidines
US8877766B2 (en) * 2013-02-15 2014-11-04 Peter F. Kador Neuroprotective multifunctional antioxidants and their monofunctional analogs
WO2023016447A1 (en) * 2021-08-09 2023-02-16 Sironax Ltd. Ferroptosis modulators, preparations, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3480617A (en) 1965-07-12 1969-11-25 Firestone Tire & Rubber Co N-(p - substituted aminophenyl) cyclic alkyleneimines and their preparation
US3586655A (en) 1965-07-12 1971-06-22 Firestone Tire & Rubber Co Use of n-(p-substituted aminophenyl) piperidines in rubbers
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
US4906634A (en) * 1988-03-08 1990-03-06 Schering A.G. Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents
JP2969359B2 (ja) * 1989-01-13 1999-11-02 武田薬品工業株式会社 環状アミン化合物

Also Published As

Publication number Publication date
EP0449195A3 (en) 1992-05-13
DE69119282T2 (de) 1996-11-14
JPH04211647A (ja) 1992-08-03
CA2038962A1 (en) 1991-09-27
JP3280040B2 (ja) 2002-04-30
DE69119282D1 (de) 1996-06-13
EP0449195A2 (de) 1991-10-02
EP0449195B1 (de) 1996-05-08

Similar Documents

Publication Publication Date Title
NZ330656A (en) Tricyclic compounds, their production and use
DE68920654D1 (de) 4-Oxochinolin-3-carbonsäure-Derivate, ihre Herstellung und ihre Verwendung.
CA2247443A1 (en) Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
DE3855875D1 (de) Thiazolidin-Derivate
IE862630L (en) 3-VINYL AND 3-ETHYNYL-ß-CARBOLINES
ATE13178T1 (de) 2-oxoazetidin-derivate, ihre herstellung und verwendung.
ATE137747T1 (de) Aminobenzolverbindungen, herstellung und verwendung
GR3003776T3 (de)
EP0598123A4 (de) Piperazinderivate und diese enthaltende arzneimittel.
ATE93517T1 (de) Mercapto-phenylalkanoylaminosaeure-amide, deren herstellung und deren verwendung als collagenase- inhibitoren.
MY131762A (en) Pharmaceutical compounds
ES2065994T3 (es) Beta-dicetonas substituidas.
ATE83234T1 (de) Oxadiazol-pyrimidinone, ihre herstellung und ihre kosmetische und dermopharmazeutische verwendung.
DE68911006D1 (de) Pharmakologisch-aktive Alkylthiobenzimidazol-Derivate und Verfahren zu deren Herstellung.
DE3764909D1 (de) E/z-isomerengemische und reine z-isomere von n alpha-(2-cyan-2-alkoximinoacetyl) aminosaeurederivaten und- peptiden.
ATE128131T1 (de) Substituierte pyridinsulfonamide oder deren salze, verfahren zur herstellung und diese enthaltende herbizide.
ATE27455T1 (de) Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
EG19396A (en) Pesticidal heterocyclic compounds
ATE24487T1 (de) Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES2112470T3 (es) Derivados de piridazinona, procedimientos de produccion y utilizacion.
CA2040011A1 (en) Thiazole and imidazole derivatives and antiulcer composition containing same
HUT39173A (en) Process for production of derivatives of 3-hydro-amino-2,3-dihydro-benzoxepin
BG46157A3 (bg) Метод за получаване на n-алкил(ен)-n-(о,о-дву- заместен тиофосфорил- n', n' - двузаместени глицинамиди
DE69022660D1 (de) Verfahren zur Herstellung von Carbamatderivaten des Lankacidines.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties